Takeda and Seattle Genetics Announce Lancet Publication of Phase 3 ALCA
CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash.--(BUSINESS WIRE)--Takeda Ph...
2017-06-14
文传商讯
Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Tr
– Data will be presented in an oral session at the annual American Soc...
2016-12-06
文传商讯
Seattle Genetics and Takeda Complete Enrollment of Phase 3 ECHELON-2 Cl
-ECHELON-2 Trial Represents Key Component of Late-Stage Clinical Development...
2016-11-10
文传商讯
Takeda to Present Broad Range of Clinical Data During 58th American Soc
– Demonstrating Expertise and Leadership in Hematologic Oncology, Pres...
2016-11-07
文传商讯
Takeda Showcases Continued Commitment in Hodgkin Lymphoma During 10th I
–Presentations highlight a range of scientific updates on ADCETRIS (brentux...
2016-10-20
文传商讯
